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Abstract
Purpose In patients with unilateral internal carotid or middle
cerebral artery (ICA or MCA) occlusive disease, the degree of
crossed cerebellar hypoperfusion that is evident within a few
months after the onset of stroke may reflect cerebral metabolic
rate of oxygen in the affected cerebral hemisphere relative to
that in the contralateral cerebral hemisphere. The aim of the
present study was to determine whether the ratio of blood flow
asymmetry in the cerebellar hemisphere to blood flow asym-
metry in the cerebral hemisphere on positron emission tomog-
raphy (PET) and single photon emission computed tomogra-
phy (SPECT) correlates with oxygen extraction fraction (OEF)
asymmetry in the cerebral hemisphere on PET in patients with
chronic unilateral ICA or MCA occlusive disease and whether
this blood flow ratio on SPECT detects misery perfusion in the
affected cerebral hemisphere in such patients.
Methods Brain blood flow and OEF were assessed using 15O-
PET and N-isopropyl-p-[123I]iodoamphetamine (123I-IMP)
SPECT, respectively. All images were anatomically standard-
ized using SPM2. A region of interest (ROI) was automatically
placed in the bilateral MCA territories and in the bilateral
cerebellar hemispheres using a three-dimensional stereotaxic
ROI template, and affected-to-contralateral asymmetry in the
MCA territory or contralateral-to-affected asymmetry in the
cerebellar hemisphere was calculated. Sixty-three patients with
reduced blood flow in the affected cerebral hemisphere on 123I-
IMP SPECTwere enrolled in this study.
Results A significant correlation was observed between MCA
ROI asymmetry of PET OEF and the ratio of cerebellar hemi-
sphere asymmetry of blood flow to MCA ROI asymmetry of
blood flow on PET (r=0.381, p=0.0019) or SPECT (r=0.459,
p=0.0001). The correlation coefficient was higher when
reanalyzed in a subgroup of 43 patients undergoing a PET
study within 3 months after the last ischemic event (r=0.541,
p=0.0001 for PET; r=0.609, p<0.0001 for SPECT). The
blood flow ratio on brain perfusion SPECT in all patients
provided 100 % sensitivity and 58 % specificity, with 43 %
positive and 100 % negative predictive values for detecting
abnormally elevated MCA ROI asymmetry of PET OEF.
Conclusion The ratio of blood flow asymmetry in the cerebel-
lar hemisphere to blood flow asymmetry in the cerebral hemi-
sphere on PETand SPECTcorrelates with PETOEF asymmetry
in the cerebral hemisphere, and this blood flow ratio on SPECT
detects misery perfusion in the affected cerebral hemisphere.
Keywords Crossed cerebellar hypoperfusion . Misery
perfusion . Oxygen extraction fraction . PET . SPECT
Introduction
In patients with major cerebral arterial occlusive disease, a
marginally adequate blood supply relative to metabolic de-
mand (misery perfusion) in the affected hemisphere [1] may
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increase the risk of cerebral infarction [2]. Misery perfusion
can be identified by demonstrating an increased oxygen
extraction fraction (OEF), which is directly measured only
through positron emission tomography (PET). Several stud-
ies have identified increased OEF as a powerful and inde-
pendent predictor of subsequent stroke in patients with
symptomatic major cerebral arterial occlusive disease [3–5].
In clinical practice, the cerebral blood flow (CBF) response
to acetazolamide can be used as an alternative parameter for
detecting impaired cerebral hemodynamics [2]. Several in-
vestigators have demonstrated that cerebrovascular reactivity
(CVR) to acetazolamide is inversely correlated with OEF
[6–10]. Further, a subgroup of patients with symptomatic
major cerebral arterial occlusive disease with reductions in
both CVR to acetazolamide and CBF measured by single
photon emission computed tomography (SPECT) has an in-
creased risk of a subsequent stroke [11, 12]. However, more
than half of patients who underwent SPECT with acetazol-
amide challenge developed adverse effects, such as headache,
nausea, dizziness, tinnitus, numbness of the extremities, and
Stevens-Johnson syndrome, after administration of the acet-
azolamide [13, 14]. These adverse events can have a signifi-
cant effect on activities of daily living and/or ability to engage
in routine employment [14].
Crossed cerebellar hypoperfusion (CCH) is defined as a
reduction in blood flow in the cerebellar hemisphere contra-
lateral to a supratentorial lesion [15]. This phenomenon can be
demonstrated on brain perfusion images obtained by SPECT
or by PET [15–18]. The mechanism underlying CCH report-
edly consists of disruption of the corticopontocerebellar path-
way that causes functional deafferentation and transneuronal
metabolic depression of the contralateral cerebellar hemi-
sphere [17, 18]. In patients with unilateral carotid artery oc-
clusive disease, contralateral-to-affected side blood flow
asymmetry in the cerebellar hemisphere reflects cerebral met-
abolic rate of oxygen (CMRO2) in the affected cerebral hemi-
sphere relative to that in the contralateral cerebral hemisphere
[19]. Because OEF is a function of CMRO2/CBF, the ratio of
contralateral-to-affected side blood flow asymmetry in the
cerebellar hemisphere to affected-to-contralateral side blood
flow asymmetry in the cerebral hemisphere may reflect
affected-to-contralateral side OEF asymmetry in the cerebral
hemisphere. If this hypothesis is correct, then misery perfu-
sion could be detected using only one brain blood flow imag-
ing study without an acetazolamide challenge.
The aim of the present study was to determine whether the
ratio of contralateral-to-affected side blood flow asymmetry in
the cerebellar hemisphere to affected-to-contralateral side
blood flow asymmetry in the cerebral hemisphere on PET
and SPECT correlates with affected-to-contralateral side
OEF asymmetry in the cerebral hemisphere on PET in patients
with chronic unilateral middle cerebral or internal carotid
artery (MCA or ICA) occlusive disease. Further, this study
investigated whether this blood flow ratio on SPECT detects
misery perfusion in the cerebral hemisphere ipsilateral to the
affected artery in such patients.
Materials and methods
Healthy volunteers
The healthy study population consisted of 20 normalmen ages
30–52 years (mean 38 years) who underwent screening based
on past history, physical examination, neurological and cog-
nitive testing, and magnetic resonance imaging (MRI) find-
ings. Exclusion criteria included any history of hypertension,
diabetes mellitus, atrial fibrillation, or pulmonary disease or
observation of organic brain lesions (including leukoaraiosis
or asymptomatic lacunar infarction) on MRI.
Patient inclusion criteria
Patients who satisfied the following basic inclusion criteria
were prospectively selected: age <75 years; presence of
clinical symptoms suggesting ischemic episodes in the
MCA or ICA territory within 6 months before visiting our
institute; absence of clinical symptoms suggesting ischemic
episodes in the vertebrobasilar territory; useful residual
function (modified Rankin disability scale 0, 1, or 2); pres-
ence of unilateral MCA or ICA stenosis (greater than 70 %
for the ICA; greater than 50 % for the MCA) or occlusion on
cerebral angiography using arterial catheterization, CT, or
MRI; absence of occlusion or stenosis of greater than 50 %
in the contralateral ICA, the contralateral MCA, the basilar
artery, and the vertebral arteries; no infarct or only subcor-
tical abnormalities (excluding infarcts involving the poste-
rior limb of the internal capsule) in the MCA territory of the
affected cerebral hemisphere on T1-, T2- and diffusion-
weighted MRI; absence of gross morphological alterations
in the cerebellum and brain stem on T1-, T2- and diffusion-
weighted MRI; and provision of written informed consent.
Finally, according to the brain perfusion SPECT criteria as
described below (see “Brain SPECTstudy” and “Data analysis”
sections), patients who were defined as having reduced blood
flow in the affected cerebral hemisphere entered into the present
study.
The study protocol was approved by the local Ethics
Committee. Written informed consent was obtained from
all subjects prior to enrollment in the study.
Brain SPECT study
SPECT studies were performed using a ring-type SPECT scan-
ner, a Headtome-SET080 (Shimadzu Corp., Kyoto, Japan),
which provides 31 tomographic images simultaneously [20].
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The spatial resolution of the scanner with a low-energy, all-
purpose collimator was 13 mm full-width at half-maximum
(FWHM) at the center of the field of view, and the slice
thickness was 25 mm FWHM at the field of view center.
Image slices were taken at 5 mm center-to-center spacing
parallel to the orbitomeatal (OM) line. The images were
reconstructed using the weighted filtered backprojection tech-
nique, in which the attenuation correctionwasmade by detecting
the edge of the object. An attenuation coefficient of 0.065 cm−1,
a Butterworth filter (cutoff=0.45 cycle/cm; order=3), and a ramp
filter were used for image reconstruction.
The distribution of brain perfusion was assessed using N-
isopropyl-p-[123I]-iodoamphetamine (IMP) and SPECT. The
IMP SPECT study was performed as described previously
[20]. Briefly, after a 1-min intravenous infusion of 222 MBq
of 123I-IMP (5-ml volume) at a constant rate of 5 ml/min and
a 1-min infusion of physiological saline at the same rate,
data acquisition was performed at a midscan time of 30 min
for a scan duration of 20 min. The IMP SPECT study was
performed at least 3 weeks after the last ischemic attack.
Brain PET study
PET studies were performed using a SET-3000GCT/M scan-
ner (PET/CT, Shimadzu Corp., Kyoto, Japan) [21]. This
modality uses gadolinium silica oxide detectors and pro-
vides 59 slices with 2.6-mm slice thickness. The axial field
of view was 156 mm, and the spatial resolution was 3.5 mm
FWHM at 1 cm in-plane and 4.2 mm FWHM at the center
axially. The scanner was operated in a static scan mode with
dual-energy window acquisition for scatter correction. The
coincidence time window was set to 10 ns. A shield module
consisting of 7-mm-thick lead plates was attached to the
gantry bed and was used to cover the breast and shoulder of
the subject to reduce the counting rate of random coinci-
dence and scatter coincidence attributable to radioactivity
outside the field of view.
Before the emission scan, a transmission scan (3 min) with
a 137Cs point source was performed with a bismuth germanate
transmission detector ring coaxially attached to the gadolini-
um silica oxide emission detector ring. Brain blood flow was
determined while the subject continuously inhaled 1,480MBq
of C15O2 through a mask. Measurements of CMRO2 and OEF
were obtained during continuous inhalation of 1,480 MBq of
15O2. Data were collected for 5 min. A single breath of
444 MBq of C15O was used to measure cerebral blood vol-
ume. Brain blood flow, CMRO2, and OEF were calculated
using the steady-state method [22], and CMRO2 and OEF
were corrected according to cerebral blood volume [23].
The PET study was performed between 2 and 6 days after
SPECT study only for patients who were defined as having
reduced blood flow in the affected cerebral hemisphere on
SPECT imaging, as described below. Patients were also
classified into subgroups of those undergoing a PET study
within (defined as early PET study) or later than (defined as
late PET study) 3 months after the last ischemic event.
Data analysis
All SPECT and PET images were transformed into the stan-
dard brain size and shape by linear and nonlinear transforma-
tion using SPM2 for anatomic standardization [24]. Thus,
brain images from all subjects had the same anatomic format.
Three hundred and eighteen constant regions of interest
(ROIs) were automatically placed in both the cerebral and
cerebellar hemispheres using a three-dimensional stereotaxic
ROI template (3DSRT) with SPM2 (FUJIFILM RI Pharma
Co., Ltd., Tokyo, Japan) [25]. The ROIs were grouped into ten
segments (callosomarginal, pericallosal, precentral, central,
parietal, angular, temporal, posterior, hippocampus, and cere-
bellar) in each hemisphere according to the arterial supply.
Five (precentral, central, parietal, angular, and temporal) of
these ten segments were combined and defined as an ROI
perfused by the MCA (Fig. 1). While the MCA ROI included
only the cerebral cortex, the cerebellar hemispheric ROI in-
cluded the cerebellar cortex as well as the cerebellar while
matter and the cerebellar ganglia. The mean value of radioac-
tive counts on 123I-IMP SPECT images and the mean value of
blood flow on PET images were measured in the bilateral
MCAs and in cerebellar hemispheric ROIs; the mean value
of CMRO2 and OEF on PET images was measured in the
bilateral MCA ROIs. Then, the asymmetry ratio in the MCA
ROI (ARMCA) was calculated as: the value in the cerebral
hemisphere ipsilateral to the side of the stenosed or occluded
artery/the value in the contralateral cerebral hemisphere. The
asymmetry ratio in the cerebellar hemispheric ROI (ARcbl)
was calculated as: the value in the cerebellar hemisphere
contralateral to the side of the stenosed or occluded artery/the
value in the ipsilateral cerebellar hemisphere.
When ARMCA in IMP SPECT was less than 0.933, a
patient was defined as having reduced blood flow in the
affected cerebral hemisphere [10] and was allowed to enter
into the present study.
Healthy volunteers were assigned to one of two groups,
each consisting of ten subjects who underwent PETor SPECT
study, respectively. In each group, the ARMCA on OEF PETor
the ARcbl/ARMCA on blood flow PET and IMP SPECT was
calculated when the left cerebral hemisphere was defined as
the affected side. An abnormally elevated ARMCA on OEF
PETwas defined as a value greater than the mean+2 standard
deviations (SDs) obtained in the healthy volunteers.
Statistical analysis
Data are expressed as the mean±SD. Correlations between
various parameters were determined using linear regression
Eur J Nucl Med Mol Imaging (2013) 40:1573–1581 1575
analysis and by computing regression equations and corre-
lation coefficients, and the function of better fit was deter-
mined. The analysis of covariance (ANCOVA), including
Levene’s test followed by pairwise comparisons, was also
used to compare the intercepts of two regression lines to test
the effect of the timing of PET study (early or late PET
study) on a dependent variable (y-axis) while controlling for
the effect of a continuous covariable (x-axis). Statistical
significance was set at the p<0.05 level. The accuracy of
ARcbl/ARMCA on blood flow SPECT to detect abnormally
elevated ARMCA on OEF PET in patients was determined by
a receiver-operating characteristic curve. The curve was
calculated in increments or decrements of 0.5 SD from the
mean value of ARcbl/ARMCA on blood flow SPECT
obtained in healthy volunteers.
Results
A total of 109 patients satisfied the basic inclusion criteria.
Among these patients, 63 were defined as having reduced
blood flow in the affected cerebral hemisphere on blood
flow SPECT imaging and entered into the present study.
The mean age of the 63 patients (21 women and 42 men)
was 59±11 years (range 34–74 years). Of the patients, 23
and 40 had experienced only transient ischemic attacks and
minor complete strokes with or without transient ischemic
attacks, respectively. Cerebral angiography demonstrated
ICA stenosis in 15 patients, ICA occlusion in 27 patients,
MCA stenosis in 12 patients, and MCA occlusion in 9
patients. Of the patients, 43 and 20 underwent early and
late PET studies, respectively.
No significant correlation was observed between ARcbl
and ARMCA on blood flow PET in patients (Fig. 2a).
However, the ARcbl correlated with ARMCA on CMRO2
PET [r=0.305, 95 % confidence interval (CI) 0.062–
0.514, p=0.0147]; while the slopes of the regression lines
between these two were statistically similar among equa-
tions of patients undergoing early and late PET studies, their
intercepts were significantly lower in an equation of patients
undergoing late PET study than in an equation of patients
undergoing early PET study (p=0.0002, mean difference
0.106, 95 % CI 0.054–0.159) (Fig. 2b). The correlation
coefficient was higher when reanalyzed in the 43 patients
undergoing early PET study (r=0.522, 95 % CI 0.262–
0.711, p=0.0003).
ARcbl/ARMCA on blood flow PET correlated with ARMCA
on OEF PET (r=0.381, 95 % CI 0.147–0.575, p=0.0019) in
patients; while the slopes of the regression lines between these
two were statistically similar among equations of patients un-
dergoing early and late PET studies, their intercepts were
significantly lower in an equation of patients undergoing late
PETstudy than in an equation of patients undergoing early PET
study (p <0.0001, mean difference 0.164, 95 % CI 0.092–
0.237) (Fig. 3). The correlation coefficient was higher when
reanalyzed in the 43 patients undergoing early PET study
(r=0.541, 95 % CI 0.288–0.724, p=0.0001).
ARMCA on blood flow SPECT correlated with ARMCA on
blood flow PET in patients (r=0.845, 95 % CI 0.755–0.903,
p<0.0001); both of the slopes and intercepts of the regres-
sion lines between these two were statistically similar
among equations of patients undergoing the early and late
PET studies (Fig. 4a). ARcbl on blood flow SPECT corre-
lated with ARcbl on blood flow PET in patients (r=0.801,
95 % CI 0.710–0.858, p<0.0001); both of the slopes and
intercepts of the regression lines between these two param-
eters were statistically similar when comparing equations of
patients undergoing the early and late PET studies (Fig. 4b).
In half of patients, ARMCA and ARcbl were higher on blood
flow SPECT than on blood flow PET. ARcbl on blood flow
SPECT correlated with ARMCA on CMRO2 PET in patients
(r=0.515, 95 % CI 0.307–0.677, p<0.0001); while the
slopes of the regression lines between these two were sta-
tistically similar among equations of patients undergoing
Fig. 1 Parts of the ROIs in a 3DSRT. ROIs surrounded by red lines
indicate the bilateral cerebellar hemispheres and cortical territories
perfused by the bilateral MCAs
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early and late PET studies, their intercepts were significantly
lower in an equation of patients undergoing late PET study
than in an equation of patients undergoing early PET study
(p=0.0001, mean difference 0.096, 95 % CI 0.051–0.140)
(Fig. 4c). The correlation coefficient was higher when
reanalyzed in the 43 patients undergoing early PET study
(r=0.653, 95 % CI 0.439–0.797, p<0.0001).
ARcbl/ARMCA on blood flow SPECT correlated with
ARMCA on OEF PET (r=0.459, 95 % CI 0.239–0.635,
p=0.0001) in patients; while the slopes of the regression
lines between these two were statistically similar among
equations of patients undergoing early and late PET studies,
their intercepts were significantly lower in an equation of
patients undergoing late PET study than in an equation of
patients undergoing early PET study (p=0.0032, mean dif-
ference 0.094, 95 % CI 0.0328–0.155) (Fig. 5). The corre-
lation coefficient was higher when reanalyzed in 43 patients
undergoing early PET study (r=0.609, 95 % CI 0.363–
0.762, p<0.0001).
The ARMCA on OEF PET in healthy volunteers was
1.001±0.044, and an abnormally elevated ARMCA on OEF
PET was defined as a value greater than 1.089. As a result,
15 patients were classified as having an abnormally elevated
ARMCA on OEF PET. The ARcbl/ARMCA on blood flow
SPECT in healthy volunteers was 0.999±0.051, and the
receiver-operating characteristic curve was calculated in in-
crements or decrements of 0.974 from 1.484 in ARcbl/ARMCA
on blood flow SPECT. The sensitivity and specificity for the
ARcbl/ARMCA on blood flow SPECT in the cutoff point lying
closest to the left upper corner of the receiver-operating char-
acteristic curve for detection of an abnormally elevated
ARMCA on OEF PET was 100 % (15/15) and 58 % (28/48)
(cutoff point 1.101), respectively (Fig. 5). Using the same
cutoff point, the positive and negative predictive values were
43 % (15/35) and 100 % (28/28), respectively. The cutoff
point for ARcbl/ARMCA on blood flow SPECT was the
mean+2 SDs of the control value obtained from normal
subjects.
When reanalyzed in 43 patients undergoing early PETstudy
using the same cutoff point, the sensitivity, specificity, and
positive and negative predictive values for the ARcbl/ARMCA
on blood flow SPECT for detection of an abnormally elevated
ARMCA on OEF PETwere 100 % (13/13), 83 % (25/30), 72%
(13/18) and 100 % (25/25), respectively (Fig. 5).
Fig. 2 Correlation between ARcbl (asymmetry ratio in the cerebellar
hemispheric ROI) on blood flow PET and ARMCA (asymmetry ratio in
the MCA ROI) on blood flow PET (a) or ARMCA on CMRO2 PET (b)
in patients. In b, open and closed circles denote patients undergoing
early and late PET studies, respectively; solid line (Y=0.399X+0.503),
dashed line (Y=0.783X+0.177), and dotted line (Y=0.346X+0.492)
denote the regression lines of all patients, those undergoing early PET
study and those undergoing late PET study, respectively
Fig. 3 Correlation between ARcbl/ARMCA on blood flow PET and
ARMCA on OEF PET in patients. Open and closed circles denote
patients undergoing early and late PET studies, respectively; solid line
(Y=0.234X+0.792), dashed line (Y=0.374X+0.661), and dotted line
(Y=0.216X+0.757) denote the regression lines of all patients, those
undergoing early PET study and those undergoing late PET study,
respectively
Eur J Nucl Med Mol Imaging (2013) 40:1573–1581 1577
Representative PET and SPECT images in two patients
with unilateral ICA occlusion and reduced blood flow in the
affected cerebral hemisphere on blood flow SPECT imaging
are shown in Fig. 6 (patient with an abnormally elevated
ARMCA onOEF PET) and Fig. 7 (patient without an abnormally
elevated ARMCA on OEF PET).
Discussion
The present study demonstrated that the ratio of
contralateral-to-affected side blood flow asymmetry in the
cerebellar hemisphere to affected-to-contralateral side blood
flow asymmetry in the cerebral hemisphere on PET and
SPECT correlates with affected-to-contralateral side OEF
asymmetry in the cerebral hemisphere on PET in patients
with chronic unilateral MCA or ICA occlusive disease.
Fig. 4 Correlation between ARMCA on blood flow SPECT and ARMCA
on blood flow PET in patients (a). Correlation between ARcbl on blood
flow SPECT and ARcbl on blood flow PET in patients (b). Correlation
between ARcbl on blood flow SPECT and ARMCA on CMRO2 PET in
patients (c).Open and closed circles denote patients undergoing early and
late PET studies, respectively; solid lines (Y=1.106X−0.087 for a, Y=
0.834X+0.151 for b, and Y=0.682X+0.232 for c), dashed lines (Y=
1.163X+0.360 for a, Y=0.690X+0.275 for b, and Y=0.866X+0.090 for
c), and dotted lines (Y=1.008X−0.012 for a, Y=0.962X+0.048 for b,
and Y=0.591X+0.259 for c) denote the regression lines of all patients,
those undergoing early PET study and those undergoing late PET study,
respectively
Fig. 5 Correlation between ARcbl/ARMCA on blood flow SPECT and
ARMCA on OEF PET in patients. The plot of the relationship between
these two values reveals four groups of results: right upper those with
elevated ARcbl/ARMCA on blood flow SPECT and elevated ARMCA on
OEF PET (true-positive); left upper those with only elevated ARMCA
on OEF PET (false-negative); left lower those without elevated ARcbl/
ARMCA on blood flow SPECT and without elevated ARMCA on OEF
PET (true-negative); and right lower those with only elevated ARcbl/
ARMCA on blood flow SPECT (false-positive). Vertical and horizontal
lines denote mean +2 SDs for ARcbl/ARMCA on blood flow SPECT and
mean +2 SDs for ARMCA on OEF PET obtained in healthy volunteers,
respectively. Open and closed circles denote patients undergoing early
and late PET studies, respectively; solid line (Y=0.345X+0.661),
dashed line (Y=0.467X+0.546), and dotted line (Y=0.157X+0.837)
denote the regression lines of all patients, those undergoing early PET
study and those undergoing late PET study, respectively
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Further, this blood flow ratio on SPECT detects misery per-
fusion in the affected cerebral hemisphere in such patients.
When a patient with a unilateral chronic ICA or MCA
occlusive disease exhibits an increase in OEF in the ipsilat-
eral cerebral hemisphere, blood flow in that hemisphere is
essentially reduced. On the other hand, even in patients with
unilateral MCA occlusive disease, the blood flow and OEF
values may be decreased and increased, respectively, in the
territory of the contralateral MCA as well as in the territory
of the ipsilateral MCA [26]. However, in such patients,
blood flow and OEF was considerably lower and higher,
respectively, in the affected MCA territory than in the
contralateral MCA territory, and the ARMCA on brain per-
fusion SPECTwith 123I-IMP was less than 0.933 [10]. Thus,
only patients with this condition on brain perfusion SPECT
with 123I-IMP finally entered into the present study.
Although the degree of blood flow asymmetry in the
MCA and cerebellar hemispheric ROIs strongly correlated
when comparing assessments by SPECT and PET, the de-
gree of blood flow asymmetry was underestimated on
SPECT when compared with PET in half of our patients.
These findings were also illustrated in blood flow asymme-
try in the cerebellar hemispheres (Fig. 6). While a previous
study demonstrated a strong correlation between CBF as
assessed by 123I-IMP SPECT and CBF as assessed by
PET, the former value tended to be underestimated as CBF
increased [20]. This may be mainly due to the limited first-
pass extraction fraction of 123I-IMP in the brain [20].
Yamauchi et al. measured brain blood flow and metabo-
lism using PET in patients with unilateral ICA or MCA
occlusive disorders and showed that while the degree of
blood flow asymmetry in the MCA territory did not differ
between patients with and without CCH, the degree of
CMRO2 asymmetry in the MCA territory was significantly
greater in patients with CCH and correlated with the degree
of CCH [19]. Results from our PET studies were consistent
with these previous findings and further demonstrated that
the degree of CCH underestimated the degree of CMRO2
asymmetry in the MCA territory in patients when assessed
at later than 3 months after the last ischemic event. Several
studies reported that CCH was not always seen in patients
with decreased CMRO2 in the cerebral hemisphere ipsilat-
eral to a major cerebral artery occlusion [27] and often
disappeared 2–3 months after onset in patients with hyper-
tensive putaminal hemorrhage [28]. The present results sup-
port these findings and suggest that while CCH essentially
reflects CMRO2 asymmetry in the cerebral hemisphere, this
phenomenon may resolve over a few months after the last
supratentorial cerebrovascular event despite the presence of
the CMRO2 asymmetry.
Several investigators have suggested that patients with
reduced CBF in the cerebral hemisphere ipsilateral to a major
cerebral artery occlusive disease might have increased OEF in
the hemisphere when CCH was not evident on PET [2, 19,
29]. This notion is supported by results from the present study
in which the ratio of the degree of CCH to the degree of blood
flow asymmetry in the MCA territory correlated with OEF
asymmetry in the MCA territory. However, this blood flow
ratio overestimated the OEF asymmetry in patients who were
assessed at later than 3 months after the last ischemic event,
which is related to the fact that CCH resolved over 3 months
after the last cerebrovascular event despite the presence of
CMRO2 asymmetry in the cerebral hemisphere.
Comparison of the present SPECT and PET studies dem-
onstrated that the degree of CCH on SPECT correlated with
Fig. 6 A 52-year-old man with symptomatic occlusion of the right
ICA. The degree of blood flow asymmetry on PET is considerably
greater in the MCA territory than in the cerebellar hemisphere. CMRO2
asymmetry in the MCA territory is not observed and OEF asymmetry
in the MCA territory is evident on PET. While blood flow asymmetry
in the MCA territory is evident on SPECT, blood flow asymmetry in
the cerebellar hemisphere is not observed on SPECT
Fig. 7 A 65-year-old man with symptomatic occlusion of the left
MCA. Blood flow asymmetry on PET is evident in the cerebellar
hemisphere as well as in the MCA territory. CMRO2 asymmetry in
the MCA territory is also evident and OEF asymmetry in the MCA
territory is not observed on PET. Blood flow asymmetry on SPECT is
evident in the cerebellar hemisphere as well as in the MCA territory
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the degree of CMRO2 asymmetry in the MCA territory on
PET and that the ratio of the degree of CCH to the degree of
blood flow asymmetry in the MCA territory on SPECT
reflected OEF asymmetry in the MCA territory. Further, this
blood flow ratio on SPECT detected misery perfusion in the
affected cerebral hemisphere with a sensitivity and negative
predictive value of 100 %. Although the specificity and pos-
itive predictive value were relatively low due to CCH resolv-
ing over 3 months after the last cerebrovascular event despite
the presence of CMRO2 asymmetry in the cerebral hemi-
sphere, the simplicity of requiring only the evaluation of
asymmetry on blood flow images makes the present SPECT
method practical. The present SPECT method also has the
advantage of not requiring acetazolamide, which is otherwise
associated with a significant risk of various adverse side
effects [13, 14]. In particular, this SPECT method is useful
as a screening test to determine whether a PETstudy is needed
in patients within 3 months after the last ischemic event.
The present study possesses limitations that require discus-
sion. First, in patients with subcortical infarctions, in addition
to primary ischemic cortical damage, secondary cerebral cor-
tical hypometabolism due to a transneuronal mechanism and
cerebrocerebellar tract damage are responsible for CCH [19].
In particular, deep infarcts destroying most of the internal
capsule frequently cause severe CCH [18]. Even an infarction
limited to the posterior limb of the internal capsule causes
CCH without hypometabolism in the ipsilateral cerebral cor-
tex [30], resulting in CCH without regard to cerebral cortical
metabolic status in patients with unilateral ICA or MCA
steno-occlusive disorders [19]. Patients with subcortical in-
farctions involving the posterior limb of the internal capsule
were thus excluded from the present study. Second, normal
values were obtained from healthy subjects whowere younger
than the patients who enrolled in this study. Abnormally
elevated ARMCA on OEF PET was defined as a value greater
than the mean+2 SDs (1.089) of the normal values. Grubb et
al. categorized patients with ARMCA on OEF PET of greater
than 1.082 due to unilateral ICA steno-occlusive disease as
having misery perfusion and reported that such patients are at
high risk for subsequent stroke when treated medically [4].
Although the cutoff point for the ARMCA on OEF PET in the
present study was approximately identical to that defined by
Grubb et al., whether or not the ARcbl/ARMCA on blood flow
SPECT can predict a higher risk of stroke recurrence remains
unknown.
Conclusion
The ratio of contralateral-to-affected side blood flow asym-
metry in the cerebellar hemisphere to affected-to-contralateral
side blood flow asymmetry in the cerebral hemisphere on PET
and SPECT correlates with affected-to-contralateral side OEF
asymmetry in the cerebral hemisphere on PET in patients with
chronic unilateral MCA or ICA occlusive disease. Further,
this blood flow ratio on brain perfusion SPECT, which can be
obtained using a single brain blood flow imaging study with-
out acetazolamide challenge, detects misery perfusion in the
affected cerebral hemisphere in such patients.
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